News
GSK and CureVac will together receive $740 million, as well as royalties on sales of COVID-19 vaccines in the US ...
1h
Zacks Investment Research on MSNKamada (KMDA) Q2 Earnings Top Estimates
Kamada (KMDA) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.08 per share a year ago. These figures are ...
8h
MONTCO Today on MSNWSJ: GSK to Receive $370M in CureVac-BioNTech Vaccine Dispute
Glaxosmithkline, which has major operations in Montgomery County, is set to receive a major settlement, writes Anthony O. Goriainoff for the Wall Street Journal. The pharmaceutical powerhouse will ...
Shortly after that, the CDC overhauled its vaccine recommendations in COVID, nixing its endorsement of the shots for pregnant women and healthy children. At the time, RFK Jr. said he “couldn’t be more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results